Lopinavir/ritonavir monotherapy substantially reduces the HIV RNA viral level in cerebrospinal fluid

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1618, 2007-01, pp. : 19-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Darunavir + ritonavir superior to lopinavir/ritonavir for HIV infection

Inpharma, Vol. 1, Iss. 1596, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Long-term lopinavir/ritonavir effective in HIV infection

Inpharma, Vol. 1, Iss. 1435, 2004-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Lopinavir/ritonavir of value across Europe for HIV

Inpharma, Vol. 1, Iss. 1619, 2008-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Lopinavir/ritonavir: a protease inhibitor for HIV-1 treatment

By Barragan Patricia Podzamczer Daniel

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 13, 2008-09 ,pp. : 2363-2375

Informa Healthcare

Access to resources Recommend Favorite

Safety of lopinavir/ritonavir for the treatment of HIV-infection

By Vogel Martin Rockstroh Jürgen K

Expert Opinion on Drug Safety, Vol. 4, Iss. 3, 2005-05 ,pp. : 403-420

Informa Healthcare

Access to resources Recommend Favorite